4oqh
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | ==Crystal structure of stabilized TEM-1 beta-lactamase variant v.13 carrying R164S mutation in complex with boron-based inhibitor EC25== | |
+ | <StructureSection load='4oqh' size='340' side='right' caption='[[4oqh]], [[Resolution|resolution]] 1.70Å' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[4oqh]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OQH OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4OQH FirstGlance]. <br> | ||
+ | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=2UL:3-[(2R)-2-{[(2R)-2-AMINO-2-PHENYLACETYL]AMINO}-2-(DIHYDROXYBORANYL)ETHYL]BENZOIC+ACID'>2UL</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene></td></tr> | ||
+ | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4ibr|4ibr]], [[4ibx|4ibx]], [[4op5|4op5]], [[4op8|4op8]], [[4opq|4opq]], [[4opr|4opr]], [[4opy|4opy]], [[4opz|4opz]], [[4oq0|4oq0]], [[4oqg|4oqg]], [[4oqi|4oqi]]</td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4oqh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4oqh OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4oqh RCSB], [http://www.ebi.ac.uk/pdbsum/4oqh PDBsum]</span></td></tr> | ||
+ | </table> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Dellus-Gur, E]] | ||
+ | [[Category: Elias, M]] | ||
+ | [[Category: Fraser, J S]] | ||
+ | [[Category: Tawfik, D S]] | ||
+ | [[Category: Beta-lactamase]] | ||
+ | [[Category: Hydrolase-hydrolase inhibitor complex]] |
Revision as of 12:15, 20 May 2015
Crystal structure of stabilized TEM-1 beta-lactamase variant v.13 carrying R164S mutation in complex with boron-based inhibitor EC25
|